PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Clinicopath Conf
Paraneoplastic Encephalitis (Limbic and Brain-Stem Encephalitis) , Case Record 39-1988, NEJM 319:849, 860,, 1988
Adverse Drug Reactions Associated with Global Cognitive Impairment in Elderly Persons
Ann Int Med 107:169-173, Larson,E.B.,et al, 1987
Treatment of Myotonia
Editorial, Lancet 1:1242-12441987., , 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Aggravation of Parkinson's Disease by Cinnarizine
JNNP 50:804-805, Marti-Masso,J.F.,et al, 1987
Traveler's Amnesia, Transient Global Amnesia Secondary to Triazolam
JAMA 258:945-946, Morris,H.H.&Estes,M.L., 1987
Brain Cardioembolism, Issues in Diagnosis & Management
Postgrad Med 82:48-57, Anderson,D.C., 1987
A Multicenter Study of Anticoagulation Parameters When Using Heparin & Warfarin
Arch Neurol 44:1229-1231, Alberts,M.J.,et al, 1987
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
Delirium Tremens, Update on an Old Disorder
Postgrad Med 82:117-122, Cushman,P., 1987
Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987
Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987
The Dandy-Walker Syndrome
In Handbk of Clin Neurology, Elsevier Publ, Amsterdam, 50:32387., Epstein,M.H.&Johanson,C.E., 1987
Effect of Calcium Antagonists on the Cerebral Circulation
(Supplement) Am J Cardiol 59:173B-176B987., Gelmers,H.J., 1987
Current Concepts in Brain Resuscitation
Arch Int Med 146:1413-1419, Kirsch,J.R.,et al, 1986
Nifedipine-Associated Acute Psychosis
Am J Med 81:705-706, Kahn,J.K., 1986
Verapamil Potentiates Carbamazephine Neurotoxicity:A Clinically Important Inhibitory Interaction
Lancet 1:700-703, Macphee,G.A.,et al, 1986
Carbamazepine Neurotoxicity Precipitated by Dilitiazem
BMJ 292:1170-1171, Brodie,M.J.,et al, 1986
Optimizing Drug Treatment of Alcohol Withdrawal
Am J Med 81:901-904, Rosenbloom,A.J., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
The Diagnosis of Myasthenia Gravis
Editorial, Lancet 1:658-6601986., , 1986
Myasthenia Gravis without Acetylcholine-Receptor Antibody:A Distinct Disease Entity
Lancet 1:116-118, Mossman,S.,et al, 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
The Pathophysiology of Penicillamine-Induced Myasthenia Gravis
Ann Neurol 20:740-744, Kuncl,R.W.,et al, 1986
Opsoclonus in Adults
Arch Neurol 43:1165-1175, Digre,K.B., 1986
Clobazam for Refractory Focal Epilepsy, A Controlled Trial
Arch Neurol 43:824-826, Schmidt,D.,et al, 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Dysosmia, Dysguesia, & Nifedipine
Ann Int Med 102:135-136, 7171985., Levenson,J.L.&Kennedy,K., 1985
Muscarinic Acetylcholine Receptors in Alzheimer's Disease
JAMA 254:3063-3066, Holman,B.L.,et al, 1985
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Calcium Channel Blockers in the Prophylactic Treatment of Vascular Headache
Ann Int Med 102:395-397, Meyer,J.S., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985
Clin. Path. Conference
Limbic Encephalitis (Paraneoplastic Encephalomyelitis) , Transitional-Cell CA of Urinary Bladder, Ca, e Re 30-1985,NEJM 313:249-257,1985., 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Flunarizine in Alternating Hemiplegia in Childhood
Lancet 2:579-580, Casaer,P.,et al, 1984
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984